# A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456

> **NCT04008849** · — · TERMINATED · sponsor: **Magenta Therapeutics, Inc.** · enrollment: 3 (actual)

## Conditions studied

- Inherited Metabolic Disorders (IMD)

## Interventions

- **OTHER:** Safety and efficacy assessments

## Key facts

- **NCT ID:** NCT04008849
- **Lead sponsor:** Magenta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-21
- **Primary completion:** 2020-10-08
- **Final completion:** 2020-10-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Due to low enrollment
- **Last updated:** 2021-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04008849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04008849, "A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04008849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*